drugset / Trial / NCT00134992

A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers

NCT00134992

Phase 4 Completed 30 enrolled Novartis
RandomizedCrossoverDouble-blindTreatment

Summary

The objective of this trial was to confirm the tolerability of prednisolone acetate 0.5% eye drops by testing the hypothesis that the ocular safety and tolerability of prednisolone acetate 0.5% eye drops are equivalent to vehicle. Thus healthy volunteers have been selected and have been treated by using a crossover design.

Timeline

Start
2004-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 0.5 % Other

Indications

No indication recorded.